Upgrade to SI Premium - Free Trial

Centessa Pharmaceuticals plc (CNTA) Tops Q3 EPS by 3c

November 12, 2024 5:04 PM

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q3 EPS of ($0.37), $0.03 better than the analyst estimate of ($0.40) .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

Categories

Earnings